Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study

1 Feb 2020

Abstract excerpt

Introduction: The Pigmented Lesion Assay (PLA) is a non-invasive gene expression test that helps clinicians rule out melanoma via a genomics approach that elevates pigmented lesion management beyond what the eye can see. PLA improves care with a negative predictive value of >99% while reducing biopsies by 90% and while reducing cost. Methods: The registry study described here (53 US dermatology offices, 90...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous Melanoma Detection and Management

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32550693
DOI: 10.36849/jdd.2020.4766

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry StudyPMID 32550693Read ↗

Genetic profiling of melanoma in routine diagnostics: assay performance and molecular characteristics in a consecutive series of 274 casesSemantic proximity Read ↗

Individualized melanoma risk prediction using machine learning with electronic health recordsSemantic proximity Read ↗

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patientsSemantic proximity Read ↗

Effectiveness of Total-Body Screening Examination in Diagnosing Melanoma at Earlier Stages: A Cohort StudySemantic proximity Read ↗

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic neviSemantic proximity Read ↗

Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma.Semantic proximity Read ↗

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patientsSemantic proximity Read ↗

Deep learning and rules-based hybrid approach to improve the accuracy of early detection of skin cancerSemantic proximity Read ↗

Use of artificial intelligence as a diagnostic support tool for skin lesions in primary care: feasibility study in clinical practiceSemantic proximity Read ↗

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile testSemantic proximity Read ↗

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?Semantic proximity Read ↗

Patient Characteristics, Motivations, and Satisfaction in an AI-Assisted Rapid-Access Pathway for the Evaluation of Skin Lesions: A Cross-Sectional Survey StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.